Scarpelli M - Search Results

1

PD-L1 assessment in urothelial carcinoma: a practical approach.

Eckstein M, Cimadamore A, Hartmann A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R, Gevaert T. Eckstein M, et al. Among authors: scarpelli m. Ann Transl Med. 2019 Nov;7(22):690. doi: 10.21037/atm.2019.10.24. Ann Transl Med. 2019. PMID: 31930091 Free PMC article. Review.

2

Liquid biopsies in renal cell carcinoma with focus on epigenome analysis.

Cimadamore A, Santoni M, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R. Cimadamore A, et al. Among authors: scarpelli m. Ann Transl Med. 2019 Sep;7(Suppl 6):S194. doi: 10.21037/atm.2019.07.30. Ann Transl Med. 2019. PMID: 31656773 Free PMC article. No abstract available.

3

PD-L1 Inhibitors for the Treatment of Prostate Cancer.

Santoni M, Massari F, Cheng L, Cimadamore A, Scarpelli M, Montironi R, Lopez-Beltran A. Santoni M, et al. Among authors: scarpelli m. Curr Drug Targets. 2020;21(15):1558-1565. doi: 10.2174/1389450121666200609142219. Curr Drug Targets. 2020. PMID: 32516098 Review.

4

TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review.

Rizzo A, Mollica V, Cimadamore A, Santoni M, Scarpelli M, Schiavina R, Cheng L, Lopez-Beltran A, Brunocilla E, Montironi R, Massari F. Rizzo A, et al. Among authors: scarpelli m. Transl Androl Urol. 2021 Mar;10(3):1541-1552. doi: 10.21037/tau-20-1109. Transl Androl Urol. 2021. PMID: 33850788 Free PMC article. Review.

5

Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer?

Barbisan F, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Kirkali Z, Montironi R. Barbisan F, et al. Among authors: scarpelli m. BJU Int. 2009 Apr;103(8):1058-63. doi: 10.1111/j.1464-410X.2008.08207.x. Epub 2008 Dec 8. BJU Int. 2009. PMID: 19076141

6

Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.

Mazzucchelli R, Barbisan F, Santinelli A, Scarpelli M, Galosi AB, Lopez-Beltran A, Cheng L, Kirkali Z, Montironi R. Mazzucchelli R, et al. Among authors: scarpelli m. Urology. 2009 Aug;74(2):385-90. doi: 10.1016/j.urology.2009.03.010. Epub 2009 Jun 7. Urology. 2009. PMID: 19501882

7

How much do you know about benign, preneoplastic, non-invasive and invasive neoplastic lesions of the urinary bladder classified according to the 2004 WHO scheme?

Montironi R, Cheng L, Scarpelli M, Mazzucchelli R, Lopez-Beltran A. Montironi R, et al. Among authors: scarpelli m. Diagn Pathol. 2011 Apr 7;6:31. doi: 10.1186/1746-1596-6-31. Diagn Pathol. 2011. PMID: 21473752 Free PMC article.

8

Clinicopathological significance of lymphovascular invasion in urothelial carcinoma.

Mazzucchelli R, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R. Mazzucchelli R, et al. Among authors: scarpelli m. Anal Quant Cytopathol Histpathol. 2012 Aug;34(4):173-9. Anal Quant Cytopathol Histpathol. 2012. PMID: 23016463 Review.

9

Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma.

Zizzi A, Montironi MA, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Paone N, Castellini P, Montironi R. Zizzi A, et al. Among authors: scarpelli m. Diagn Pathol. 2013 Jul 2;8:111. doi: 10.1186/1746-1596-8-111. Diagn Pathol. 2013. PMID: 23819605 Free PMC article.

10

Urothelial dysplasia of the bladder: diagnostic features and clinical significance.

Lopez-Beltran A, Montironi R, Vidal A, Scarpelli M, Cheng L. Lopez-Beltran A, et al. Among authors: scarpelli m. Anal Quant Cytopathol Histpathol. 2013 Jun;35(3):121-9. Anal Quant Cytopathol Histpathol. 2013. PMID: 24344498 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

512 results

Search Page